Cargando…

Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009–2011. An Update for Clinicians

Attention deficit/hyperactivity disorder (ADHD) is a common disorder and a plethora of new data has been published from clinical trials and national epidemiological databases in the last three years. In the United Kingdom Atomoxetine is currently the only licensed non-stimulant medication. As part o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bushe, Chris J., Savill, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663616/
https://www.ncbi.nlm.nih.gov/pubmed/23861650
http://dx.doi.org/10.4137/JCNSD.S4391
_version_ 1782271008574537728
author Bushe, Chris J.
Savill, Nicola
author_facet Bushe, Chris J.
Savill, Nicola
author_sort Bushe, Chris J.
collection PubMed
description Attention deficit/hyperactivity disorder (ADHD) is a common disorder and a plethora of new data has been published from clinical trials and national epidemiological databases in the last three years. In the United Kingdom Atomoxetine is currently the only licensed non-stimulant medication. As part of a systematic review of atomoxetine data Jan 2009–June 2011 formal searches found 750 citations. From these 13 met criteria for either review or systematic review papers and contained clinical data synthesis on atomoxetine. No individual review paper alone would be sufficient for clinicians to be updated at that time on all clinical aspects of atomoxetine data. The crucial data relating to clinical parity of atomoxetine and methylphenidate in trials and meta-analysis where relevant confounding biases are removed are not often discussed. Systematic review of complex data is critical for ADHD clinicians and will need regular updating due to the large volume of new data.
format Online
Article
Text
id pubmed-3663616
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Libertas Academica
record_format MEDLINE/PubMed
spelling pubmed-36636162013-07-16 Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009–2011. An Update for Clinicians Bushe, Chris J. Savill, Nicola J Cent Nerv Syst Dis Expert Review Attention deficit/hyperactivity disorder (ADHD) is a common disorder and a plethora of new data has been published from clinical trials and national epidemiological databases in the last three years. In the United Kingdom Atomoxetine is currently the only licensed non-stimulant medication. As part of a systematic review of atomoxetine data Jan 2009–June 2011 formal searches found 750 citations. From these 13 met criteria for either review or systematic review papers and contained clinical data synthesis on atomoxetine. No individual review paper alone would be sufficient for clinicians to be updated at that time on all clinical aspects of atomoxetine data. The crucial data relating to clinical parity of atomoxetine and methylphenidate in trials and meta-analysis where relevant confounding biases are removed are not often discussed. Systematic review of complex data is critical for ADHD clinicians and will need regular updating due to the large volume of new data. Libertas Academica 2011-12-05 /pmc/articles/PMC3663616/ /pubmed/23861650 http://dx.doi.org/10.4137/JCNSD.S4391 Text en © 2011 the author(s), publisher and licensee Libertas Academica Ltd. This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited.
spellingShingle Expert Review
Bushe, Chris J.
Savill, Nicola
Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009–2011. An Update for Clinicians
title Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009–2011. An Update for Clinicians
title_full Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009–2011. An Update for Clinicians
title_fullStr Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009–2011. An Update for Clinicians
title_full_unstemmed Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009–2011. An Update for Clinicians
title_short Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009–2011. An Update for Clinicians
title_sort atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder. systematic review of review papers 2009–2011. an update for clinicians
topic Expert Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663616/
https://www.ncbi.nlm.nih.gov/pubmed/23861650
http://dx.doi.org/10.4137/JCNSD.S4391
work_keys_str_mv AT bushechrisj atomoxetineinchildrenandadolescentswithattentiondeficithyperactivitydisordersystematicreviewofreviewpapers20092011anupdateforclinicians
AT savillnicola atomoxetineinchildrenandadolescentswithattentiondeficithyperactivitydisordersystematicreviewofreviewpapers20092011anupdateforclinicians